This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

With Musk's US trial against OpenAI near, new battle over remedies emerges

By Amy Miller and Mike Swift ( April 13, 2026, 22:30 GMT | Comment) -- OpenAI and Microsoft are accusing Elon Musk of “injecting chaos” and “sandbagging the defendants” two weeks before their high-profile trial over the legality of OpenAI’s conversion to for-profit status. The fresh court filings come in the wake of Musk's bid last week to change the remedy he's seeking in the case, asking that a jury restore OpenAI to non-profit status and strip Sam Altman of his status at OpenAI's CEO.Pitched complaints about “a coordinated PR campaign” and “legal ambush.” Counter claims about “restoring the OpenAI charity to its rightful role.” Days before a high-profile trial between Elon Musk and OpenAI, the judicial theater is already building....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections